COAPROZAR
DCI : IRBESARTAN+HYDROCHLOROTHIAZIDE
Dosage 300 mg/25 mg
Pharmaceutical form Coated tablet
Therapeutic class Cardiology-Engiology
B/30
Indications
Treatment of essential hypertension. This fixed dose combination is indicated in patients whose blood pressure is not adequately controlled by irbesartan alone or hydrochlorothiazide alone.
Download the leaflet
